Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking a Director of Clinical Quality to lead quality assurance and provide quality and compliance oversight for RevMed-sponsored clinical trials. The role will support daily compliance operational activities, evaluate risk, and resolve quality events for early phase through late-phase clinical programs.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Iambic Therapeutics, Inc